Discontinued Operations - Additional Information (Details) - USD ($)		12 Months Ended
	Aug. 16, 2021	Dec. 31, 2021	Dec. 31, 2020
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]
Common stock, shares issued		7,010	3,189
Common stock, par value		$ 0.0001	$ 0.0001
Gain on sale of business		$ 3,473,000
Dermatology [Member]
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]
Depreciation expense		300,000	$ 400,000
Capital expenditure		0	0
Provision for credit losses			100,000
Stock based compensation expense		18,000	200,000
Stock based compensation expense capitalized to inventory and property and equipment		100,000	$ 200,000
Dermatology [Member] | Disposition by Sale [Member]
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]
Gain on sale of business		$ 3,500,000
Dermatology [Member] | Discontinued Operations [Member] | Disposition by Sale [Member]
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]
Cash on disposition of business	$ 3,700,000
Broker and legal fees on disposal	$ 200,000
Dermatology [Member] | Warrant [Member] | Discontinued Operations [Member] | Disposition by Sale [Member]
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]
Common stock, shares issued	74,247
Common stock, par value	$ 2.99
Warrant expiry period	5 years
Warrant	$ 100,000
Expected volatility rate	104.55%
Risk free interest rate	0.32%
Expected dividend rate	0.00%
Expected term	2 years 6 months